CHM already has a cornerstone invester. So we shouldn't need any CR for a while.
Not a large SOC with even smaller free float. So any fund buy on market would more the share price disproportionately. So they may find it difficult taking a significant holding.
CHM has a crazily low market cap for its pipeline. 5 bags from where we are now would still be fair value. Double that when the NK trial hits arms and if results are as expected. And then more trials on the way.
Still lots of risk. But the drugs and company employees all come from places of high pedigree. The pipeline is novel, and addressing markets with no effective SOC.
This one is going to be worth the wait. Tales of buying at this share price will bore dinner guests in years to come.
CHM Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)